Organism | Drug, Dose, Duration | Comments |
Streptococci |
Penicillin-susceptibleb streptococci, S. bovis | Penicillin G (2-3 mU IV q4h for 4 weeks) | — |
| Ceftriaxone (2 g/d IV as a single dose for 4 weeks) | Can use ceftriaxone in pts with nonimmediate penicillin allergy |
| Vancomycinc (15 mg/kg IV q12h for 4 weeks) | Use vancomycin in pts with severe or immediate β-lactam allergy |
| Penicillin G (2-3 mU IV q4h) or ceftriaxone (2 g IV qd) for 2 weeks plus gentamicind (3 mg/kg qd IV or IM as a single dosee or divided into equal doses q8h for 2 weeks) | Avoid 2-week regimen when risk of aminoglycoside toxicity is increased and in prosthetic valve or complicated endocarditis |
Relatively penicillin-resistantf streptococci | Penicillin G (4 mU IV q4h) or ceftriaxone (2 g IV qd) for 4 weeks plus gentamicind (3 mg/kg qd IV or IM as a single dosee or divided into equal doses q8h for 2 weeks) Vancomycinc as noted above for 4 weeks | Penicillin alone at this dose for 6 weeks or with gentamicin during initial 2 weeks preferred for prosthetic valve endocarditis caused by streptococci with penicillin MICs of ≤0.1 μg/mL |
Moderately penicillin-resistantg streptococci, nutritionally variant organisms, or Gemella morbillorum | Penicillin G (4-5 mU IV q4h) or ceftriaxone (2 g IV qd) for 6 weeks plus gentamicind (3 mg/kg qd IV or IM as a single dosee or divided into equal doses q8h for 6 weeks) Vancomycinc as noted above for 4 weeks | Preferred for prosthetic valve endocarditis caused by streptococci with penicillin MICs of >0.1 μg/mL |
Enterococcih | Penicillin G (4-5 mU IV q4h) plus gentamicind (1 mg/kg IV q8h), both for 4-6 weeks | Can use streptomycin (7.5 mg/kg q12h) in lieu of gentamicin if there is not high-level resistance to streptomycin |
| Ampicillin (2 g IV q4h) plus gentamicind (1 mg/kg IV q8h), both for 4-6 weeks | — |
| Vancomycinc (15 mg/kg IV q12h) plus gentamicind (1 mg/kg IV q8h), both for 4-6 weeks | Use vancomycin plus gentamicin for penicillin-allergic pts, or desensitize these pts to penicillin |
Staphylococci |
Methicillin-susceptible, infecting native valves (no foreign devices) | Nafcillin or oxacillin (2 g IV q4h for 4-6 weeks) plus (optional) gentamicind (1 mg/kg IM or IV q8h for 3-5 days) | Can use penicillin (4 mU q4h) if isolate is penicillin-susceptible (does not produce β-lactamase) |
| Cefazolin (2 g IV q8h for 4-6 weeks) plus (optional) gentamicind (1 mg/kg IM or IV q8h for 3-5 days) | Can use cefazolin regimen for pts with nonimmediate penicillin allergy |
| Vancomycinc (15 mg/kg IV q12h for 4-6 weeks) | Use vancomycin for pts with immediate (urticarial) or severe penicillin allergy |
Methicillin-resistant, infecting native valves (no foreign devices) | Vancomycinc (15 mg/kg IV q12h for 4-6 weeks) | No role for routine use of rifampin |
Methicillin-susceptible, infecting prosthetic valves | Nafcillin or oxacillin (2 g IV q4h for 6-8 weeks) plus gentamicind (1 mg/kg IM or IV q8h for 2 weeks) plus rifampini (300 mg PO q8h for 6-8 weeks) | Use gentamicin during initial 2 weeks; determine susceptibility to gentamicin before initiating rifampin; if pt is highly allergic to penicillin, use regimen for methicillin-resistant staphylococci; if β-lactam allergy is of the minor, nonimmediate type, can substitute cefazolin for oxacillin/nafcillin |
Methicillin-resistant, infecting prosthetic valves | Vancomycinc (15 mg/kg IV q12h for 6-8 weeks) plus gentamicind (1 mg/kg IM or IV q8h for 2 weeks) plus rifampini (300 mg PO q8h for 6-8 weeks) | Use gentamicin during initial 2 weeks; determine gentamicin susceptibility before initiating rifampin |
HACEK organisms | Ceftriaxone (2 g/d IV as single dose for 4 weeks) | Can use another third-generation cephalosporin at comparable dosage |
| Ampicillin/sulbactam (3 g IV q6h for 4 weeks) | — |